IRIS UniCatt

Alivernini, Stefano
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.564
AS - Asia 3.470
EU - Europa 3.217
SA - Sud America 740
AF - Africa 109
Continente sconosciuto - Info sul continente non disponibili 6
OC - Oceania 6
AN - Antartide 1
Totale 12.113
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.416
SG - Singapore 1.614
CN - Cina 798
IT - Italia 691
BR - Brasile 603
SE - Svezia 480
DE - Germania 409
PL - Polonia 405
FR - Francia 389
VN - Vietnam 346
IE - Irlanda 164
GB - Regno Unito 155
IN - India 128
HK - Hong Kong 116
FI - Finlandia 113
UA - Ucraina 100
ID - Indonesia 97
RU - Federazione Russa 76
JP - Giappone 73
CA - Canada 66
BD - Bangladesh 57
MX - Messico 54
AR - Argentina 47
NL - Olanda 43
TR - Turchia 42
IQ - Iraq 40
ZA - Sudafrica 37
BE - Belgio 31
AT - Austria 29
KR - Corea 28
ES - Italia 25
EC - Ecuador 22
VE - Venezuela 18
PK - Pakistan 17
LT - Lituania 16
CI - Costa d'Avorio 15
IR - Iran 15
CH - Svizzera 14
CO - Colombia 14
IL - Israele 13
MA - Marocco 12
TN - Tunisia 11
PE - Perù 10
SA - Arabia Saudita 10
CL - Cile 9
CZ - Repubblica Ceca 9
RO - Romania 9
AE - Emirati Arabi Uniti 8
GR - Grecia 8
KE - Kenya 8
PH - Filippine 8
UZ - Uzbekistan 8
PT - Portogallo 7
HN - Honduras 6
MY - Malesia 6
PY - Paraguay 6
TW - Taiwan 6
UY - Uruguay 6
AL - Albania 5
AU - Australia 5
BO - Bolivia 5
EE - Estonia 5
KZ - Kazakistan 5
LV - Lettonia 5
MD - Moldavia 5
SK - Slovacchia (Repubblica Slovacca) 5
SN - Senegal 5
DK - Danimarca 4
HU - Ungheria 4
JM - Giamaica 4
JO - Giordania 4
NP - Nepal 4
AO - Angola 3
AZ - Azerbaigian 3
DO - Repubblica Dominicana 3
GE - Georgia 3
KG - Kirghizistan 3
LA - Repubblica Popolare Democratica del Laos 3
NG - Nigeria 3
PA - Panama 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AM - Armenia 2
BB - Barbados 2
BG - Bulgaria 2
BY - Bielorussia 2
EG - Egitto 2
ET - Etiopia 2
EU - Europa 2
KH - Cambogia 2
KW - Kuwait 2
LB - Libano 2
LK - Sri Lanka 2
LU - Lussemburgo 2
MM - Myanmar 2
OM - Oman 2
RS - Serbia 2
SV - El Salvador 2
XK - ???statistics.table.value.countryCode.XK??? 2
AQ - Antartide 1
BA - Bosnia-Erzegovina 1
Totale 12.090
Salva come PNG Salva come JPEG
Città #
Singapore 891
Chandler 508
Ashburn 492
Warsaw 379
San Jose 352
Rome 181
New York 172
Fairfield 168
Beijing 150
Dublin 146
Los Angeles 132
Wilmington 120
Ho Chi Minh City 112
Dearborn 104
Hong Kong 102
The Dalles 102
Dallas 98
Woodbridge 98
Ann Arbor 96
Seattle 95
Milan 94
Jakarta 91
Lauterbourg 87
Chicago 86
Houston 81
Hanoi 77
Nanjing 72
Hefei 69
Cambridge 68
Munich 65
Cattolica 62
Tokyo 62
São Paulo 60
Boston 55
Jacksonville 55
Frankfurt am Main 53
San Mateo 53
Helsinki 51
Princeton 50
Bremen 44
London 42
Marseille 37
Council Bluffs 34
Moscow 29
Redwood City 28
North Bergen 27
Orem 26
Paris 26
Brussels 25
Santa Clara 25
Izmir 24
Nuremberg 24
Pune 24
Tianjin 24
Lappeenranta 23
Redmond 22
Montreal 21
Seoul 21
Boardman 20
Chennai 20
Denver 20
Haiphong 20
Phoenix 20
Lawrence 19
Nanchang 19
Stockholm 19
Da Nang 18
Johannesburg 18
Toronto 18
Baghdad 17
Salt Lake City 17
Shanghai 17
Brasília 16
Guangzhou 16
Kunming 16
Turku 16
Abidjan 15
Norwalk 15
Shenyang 15
Atlanta 14
Buffalo 14
Elk Grove Village 14
Hangzhou 14
Kent 14
Lancaster 14
Mexico City 14
San Francisco 14
Vienna 14
St Louis 13
Amsterdam 11
Andover 11
Brooklyn 11
Curitiba 11
Roubaix 11
Washington 11
Dhaka 10
Dong Ket 10
Hebei 10
Mountain View 10
Porto Alegre 10
Totale 6.941
Salva come PNG Salva come JPEG
Nome #
MicroRNA-34a dependent regulation of AXL controls the activation of dendritic cells in inflammatory arthritis 344
Differential synovial tissue biomarkers among psoriatic arthritis and rheumatoid factor/anti-citrulline antibody-negative rheumatoid arthritis 340
Overweight/obesity affects histological features and inflammatory gene signature of synovial membrane of Rheumatoid Arthritis 304
B cell subsets in the joint compartments of seropositive and seronegative RA and non-RA arthritides express memory markers and ZAP-70 and characterize the aggregate pattern irrespectively of the autoantibody status. 263
MicroRNA-155-at the Critical Interface of Innate and Adaptive Immunity in Arthritis. 257
Distinct synovial tissue macrophage subsets regulate inflammation and remission in rheumatoid arthritis 240
Fatigue in Covid-19 survivors: The potential impact of a nutritional supplement on muscle strength and function 230
Synovial tissue macrophages: friend or foe? 210
Fatigue in Covid-19 survivors: The potential impact of a nutritional supplement on muscle strength and function 208
Chemerin and PEDF are metaflammation-related biomarkers of disease activity and obesity in rheumatoid arthritis 207
B-cell subsets in the joint compartments of seropositive and seronegative rheumatoid arthritis (RA) and No-RA arthritides express memory markers and ZAP70 and characterize the aggregate pattern irrespectively of the autoantibody status 203
Malnutrition in COVID-19 survivors: prevalence and risk factors 190
Synovial tissue derived characteristics are included in a nomogram for the prediction of treatment response in naïve Rheumatoid Arthritis 190
MicroRNA-155 influences B-cell function through PU.1 in rheumatoid arthritis 184
Haemophilus parasuis (Glaesserella parasuis) as a Potential Driver of Molecular Mimicry and Inflammation in Rheumatoid Arthritis 180
Malnutrition in COVID-19 survivors: prevalence and risk factors 178
COVID-19 atypical Parsonage-Turner syndrome: a case report 174
ZAP-70+ B Cell Subset Influences Response to B Cell Depletion Therapy and Early Repopulation in Rheumatoid Arthritis 171
Systemic Bone Density at Disease Onset Is Associated With Joint Erosion Progression in Early Naive to Treatment Rheumatoid Arthritis: A Prospective 12-Month Follow-Up Open-Label Study 170
A single cell atlas of frozen shoulder capsule identifies features associated with inflammatory fibrosis resolution 167
Psychological Distress After Covid-19 Recovery: Reciprocal Effects With Temperament and Emotional Dysregulation. An Exploratory Study of Patients Over 60 Years of Age Assessed in a Post-acute Care Service 160
Tapering and discontinuation of TNF-α blockers without disease relapse using ultrasonography as a tool to identify patients with rheumatoid arthritis in clinical and histological remission 159
Collagen Specific T-Cell Repertoire and HLA-DR Alleles: Biomarkers of Active Refractory Rheumatoid Arthritis 157
Postural control and disability in patients with early rheumatoid arthritis 157
Has shoulder ultrasonography got a predictive value in Polymialgia Rheumatica. In: EULAR. 155
Synovial features of patients with rheumatoid arthritis and psoriatic arthritis in clinical and ultrasound remission differ under anti-TNF therapy: A clue to interpret different chances of relapse after clinical remission? 154
EULAR points to consider for minimal reporting requirements in synovial tissue research in rheumatology 154
Sarilumab use in severe SARS-CoV-2 pneumonia 153
Bronchoalveolar lavage fluid and progression of scleroderma interstitial lung disease 152
Recommendations for the use of biologic therapy in rheumatoid arthritis: update from the Italian Society for Rheumatology I. Efficacy 144
Characterization of inflammatory cell infiltrate of scleroderma skin: B cells and skin score progression. 144
The pathogenesis of rheumatoid arthritis 141
Collagen Specific T-Cell Repertoire and HLA-DR Alleles: Biomarkers of Active Refractory Rheumatoid Arthritis 141
PTPN22 1858C>T polymorphism distribution in Europe and association with rheumatoid arthritis: case-control study and meta-analysis 138
No higher risk of respiratory symptoms in Italian rheumatological patients under IL-6R-inhibitor therapy in SARS-CoV-2 pandemic 138
Synovial tissue macrophages in joint homeostasis, rheumatoid arthritis and disease remission 134
Biomolecular features of inflammation in obese rheumatoid arthritis patients: management considerations 131
Rituximab Followed by Belimumab Controls Severe Lupus Nephritis and Bullous Pemphigoid in Systemic Lupus Erythematosus Refractory to Several Combination Therapies 131
Comparative analysis of synovial inflammation after SARS-CoV-2 infection 128
Checkpoint inhibitors (CPI) and autoimmune chronic inflammatory diseases (ACIDs): tolerance and loss of tolerance in the occurrence of immuno-rheumatologic manifestations 127
Bispecific T cell engager therapy for refractory rheumatoid arthritis 123
Infectious agents breaking the immunological tolerance: The holy grail in rheumatoid arthritis reconsidered 122
Paradoxical arthritis occurring during anti-TNF in patients with Inflammatory Bowel Disease: histological and immunological features of a complex synovitis. 121
Intensive training programme for ultrasound-guided minimally invasive synovial tissue biopsy on knees and wrists in different phases of inflammation 120
Synovial predictors of differentiation to definite arthritis in patients with seronegative undifferentiated peripheral inflammatory arthritis: MicroRNA signature, histological, and ultrasound features 119
Rituximab Followed by Belimumab Controls Severe Lupus Nephritis and Bullous Pemphigoid in Systemic Lupus Erythematosus Refractory to Several Combination Therapies 119
Fatigue in Covid-19 survivors: The potential impact of a nutritional supplement on muscle strength and function 116
No higher risk of respiratory symptoms in Italian rheumatological patients under IL-6R-inhibitor therapy in SARS-CoV-2 pandemic 116
Peripheral blood CD4posCD25posFoxP3pos cells and inflammatory cytokines as biomarkers of response in rheumatoid arthritis patients treated with CTLA4-Ig 115
CTLA-4 Ig as an effective treatment in a patient with type I diabetes mellitus and seropositive rheumatoid arthritis 114
Collagen Specific T-Cell Repertoire and HLA-DR Alleles: Biomarkers of Active Refractory Rheumatoid Arthritis 112
Immunosuppressive Therapy (Methotrexate or Cyclophosphamide) in Combination with Corticosteroids in the Treatment of Giant Cell Arteritis: Comparison with Corticosteroids Alone 111
Rheumatoid arthritis and Alzheimer's disease: genetic and epigenetic links in inflammatory regulation 110
Synovial tissue myeloid dendritic cell subsets exhibit distinct tissue-niche localization and function in health and rheumatoid arthritis 109
Interleukin-6 and IgA-rheumatoid factor are crucial for baseline erosiveness, and anti-citrullinated peptide antibodies for radiographic progression in early rheumatoid arthritis treated according to a treat-to-target strategy 109
CTLA-4 Ig as an effective treatment in a patient with type I diabetes mellitus and seropositive rheumatoid arthritis 106
Minimally invasive retrieval and characterisation of tenosynovial tissue in rheumatoid arthritis: a novel approach to study at-risk, active, and remission stages 105
Comment on: Emergence of severe spondyloarthropathy-related entheseal pathology following successful vedolizumab therapy for inflammatory bowel disease 103
COVID-19 and RA share an SPP1 myeloid pathway that drives PD-L1+ neutrophils and CD14+ monocytes 102
Using explainable artificial intelligence to predict and forestall flare in rheumatoid arthritis 101
Basic immunology may lead to translational therapeutic rationale: SARS-CoV-2 and rheumatic diseases 101
Adult-onset Still’s disease: an Italian multicentre retrospective observational study of manifestations and treatments in 245 patients 99
Real-life effectiveness of ustekinumab in inflammatory bowel disease patients with concomitant psoriasis or psoriatic arthritis: An IG-IBD study 99
Differential synovial tissue biomarkers among psoriatic arthritis and rheumatoid factor/anti-citrulline antibody-negative rheumatoid arthritis 97
Bronchoalveolar lavage fluid and progression of scleroderma interstitial lung disease 96
Amplifying the concept of psoriatic arthritis: The role of autoimmunity in systemic psoriatic disease 94
The B side of rheumatoid arthritis pathogenesis 92
RAASI, NSAIDs, antidiabetics, and anticoagulants: More data needed to be labeled as harmful or neutral in SARS-CoV-2 infection 92
Ultrasound assessment as predictor of disease relapse in children and adults with arthritis in clinical stable remission: new findings but still unmet needs 91
The Role of Neutrophils in Spondyloarthritis: A Journey across the Spectrum of Disease Manifestations 90
A multiparametric risk table for loss of clinical remission status in patients with rheumatoid arthritis: A starter study post-hoc analysis 89
Biomarkers of joint damage in rheumatoid arthritis: where are we in 2013? 89
Should rheumatoid factor (RF) (and antinuclear antibodies (ANA)) become routinary screening test for morbidities in the general population?: From the concept of “benign autoimmunity “to the concept of” autoimmunity as a red flag in preventive medicine”? 89
Telemedicine will not keep us apart in COVID-19 pandemic 89
JAK inhibition by methotrexate (and csDMARDs) may explain clinical efficacy as monotherapy and combination therapy 88
Laboratory Monitoring of Biological Therapies in Rheumatology: The Role of Immunogenicity 88
From Bed to Bench and Back: TNF-α, IL-23/IL-17A, and JAK-Dependent Inflammation in the Pathogenesis of Psoriatic Synovitis 86
Loss of α2-6 sialylation promotes the transformation of synovial fibroblasts into a pro-inflammatory phenotype in arthritis 85
Pro Nerve Growth Factor and Its Receptor p75NTR Activate Inflammatory Responses in Synovial Fibroblasts: A Novel Targetable Mechanism in Arthritis 85
Is ACPA positivity the main driver for rheumatoid arthritis treatment? Pros and cons 84
Ecografia delle spalle in pazienti con PR: valore diagnostico ma non predittivo 82
Measuring the T-cell down-regulation of TCR-zeta, ZAP-70 and CD28 in arthritis patients: An old tool for new biomarkers 76
The Role of High-Mobility Group Box-1 and Its Crosstalk with Microbiome in Rheumatoid Arthritis 73
Interleukin-6 and IgA-rheumatoid factor are crucial for baseline erosiveness, and anti-citrullinated peptide antibodies for radiographic progression in early rheumatoid arthritis treated according to a treat-to-target strategy 72
Exploring perinatal mesenchymal stromal cells as a potential therapeutic strategy for rheumatoid arthritis 70
COVID-19 and RA share an SPP1 myeloid pathway that drives PD-L1+ neutrophils and CD14+ monocytes 68
High CD14+ peripheral monocytes expression of ALX/FPR2 and BLT1 in low disease activity and remission status in rheumatoid arthritis: a piltot study 68
Anti-LL37 antibodies are present in psoriatic arthritis (PsA) patients: New biomarkers in PsA 68
Inflammation causes remodeling of mitochondrial cytochrome c oxidase mediated by the bifunctional gene C15orf48 67
High CD14+ peripheral monocytes expression of ALX/FPR2 and BLT1 in low disease activity and remission status in rheumatoid arthritis: a piltot study 63
Driving chronicity in rheumatoid arthritis: Perpetuating role of myeloid cells 59
Evaluating antirheumatic treatments using synovial biopsy: A recommendation for standardisation to be used in clinical trials 49
Skin ulcers in systemic sclerosis: determinants of presence and predictive factors of healing 48
PTPN22 1858C>T polymorphism distribution in Europe and association with rheumatoid arthritis: case-control study and meta-analysis 42
Totale 12.289
Salva come PNG Salva come JPEG
Categoria #
all - tutte 52.274
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 52.274
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021160 0 0 0 0 0 0 0 0 0 63 72 25
2021/2022719 95 46 32 52 45 18 15 74 44 51 97 150
2022/20231.525 177 184 114 231 115 187 65 121 191 62 51 27
2023/20241.056 42 219 50 52 43 189 96 37 39 70 141 78
2024/20252.054 36 38 152 97 149 83 90 88 303 230 391 397
2025/20264.638 735 194 367 617 805 292 802 252 270 304 0 0
Totale 12.289